tki and checkpoint inhibitor combinations for kidney cancer: the immotion151 trial
Published 6 years ago • 136 plays • Length 2:02Download video MP4
Download video MP3
Similar videos
-
1:34
identifying predictive markers for checkpoint inhibitor response in kidney cancer
-
41:21
the role of tyrosine kinase inhibitors and mtor inhibitors
-
1:15
overcoming immune checkpoint inhibitor resistance in kidney cancer
-
4:49
frontline tki strategies in kidney cancer
-
1:06
promising tki-ici combinations for non-clear cell rcc
-
6:07
sequential use of immune checkpoint inhibitors in renal cell carcinoma
-
2:07
immune checkpoint inhibitors, the next generation cancer therapy - creative biolabs
-
1:40
dr. choueiri on checkpoint inhibitor/tki combinations in rcc
-
1:50
bionikk: the first trial study in mccrcc
-
51:09
immunotherapy-based combinations for advanced/metastatic renal cell carcinoma: asco gu 2023
-
4:58
researcher comment: the keynote-146/study 111 trial | chung-han lee
-
4:44
vegfr inhibitors with immune checkpoint inhibitors for advanced renal cancer
-
5:11
current treatment landscape for kidney cancer
-
3:15
a novel approach: tki/i-o combinations in rcc
-
52:18
immune checkpoint inhibitors and rcc: where are we now?
-
1:06
key trials in kidney cancer at asco gu 2023
-
2:15
kidney cancer at asco gu: papmet & clear
-
1:20
renal cell carcinoma: the emulsion and checkmate 214 trials
-
0:55
the emerging continuum of care in metastatic kidney cancer in the second-line and beyond